A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

This study has been completed.

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00293761

Purpose

The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Condition	Intervention	Phase
Open-Angle Glaucoma Ocular Hypertension	Drug: Travoprost	Phase III

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma High Blood Pressure

Drug Information available for: Travoprost

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Further study details as provided by Alcon Research:

Primary Outcome Measures:

Mean IOP

Estimated Enrollment:	100
Study Start Date:	January 2006

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adult patients of either sex of any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension

Exclusion Criteria:

Under age 18

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00293761

Locations

United States, Texas
United States Investigate Sites in Texas and Other States
Fort Worth, Texas, United States, 76180

Sponsors and Collaborators

Alcon Research

Investigators

Principal Investigator:

Theresa Landry, PhD

Alcon Research

More Information

Study ID Numbers:	C-05-51
Study First Received:	February 17, 2006
Last Updated:	April 20, 2007
ClinicalTrials.gov Identifier:	NCT00293761
Health Authority:	United States: Food and Drug Administration

Keywords provided by Alcon Research:

open-angle
glaucoma
ocular
hypertension

Study placed in the following topic categories:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases

Travoprost
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:

Therapeutic Uses
Cardiovascular Diseases
Cardiovascular Agents
Antihypertensive Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 14, 2009